December 18, 2018

Researchers explore the latest advances in Cryptosporidium research at Tufts University.

October 31, 2018

Dr. Wes Van Voorhis is conducting a Phase 2A, clinical trial on the safety, tolerability, pharmacokinetics and efficacy of clofazimine in Cryptosporidiosis.